Escitalopram in the treatment of social anxiety disorder: Analysis of efficacy for different clinical subgroups and symptom dimensions

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Depression and Anxiety

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/DA.20043PMID 15643634
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Escitalopram in the treatment of social anxiety disorder

  2005cited by this paper
• Efficacy and tolerability of escitalopram in 12‐ and 24‐week treatment of social anxiety disorder: Randomised, double‐blind, placebo‐controlled, fixed‐dose study

  2004cited by this paper
• A confirmatory factor analysis of a self-report version of the Liebowitz Social Anxiety Scale.

  2003cited by this paper
• Quality of Life in Anxiety Disorders: A Comparison of Obsessive-Compulsive Disorder, Social Anxiety Disorder, and Panic Disorder

  2003cited by this paper
• The evidence-based pharmacological treatment of social anxiety disorder.

  2003cited by this paper
• P.3.025 Relapse prevention by escitalopram treatment of patients with social anxiety disorder (SAD)

  2003cited by this paper
• Social anxiety disorder and generalized anxiety disorder: serotonergic and dopaminergic neurocircuitry.

  2002influential reference
• Predictors of response to pharmacotherapy in social anxiety disorder: an analysis of 3 placebo-controlled paroxetine trials.

  2002influential reference
• The social anxiety spectrum.

  2002cited by this paper
• Moclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without comorbid anxiety disorder

  2002influential reference
• Putative clinical subtypes of social phobia: a factor-analytical study

  2001cited by this paper
• Putative clinical subtypes of social phobia:a factor‐analytical study

  2001cited by this paper
• The selective serotonin reuptake inhibitor paroxetine is effective in more generalized and in less generalized social anxiety disorder

  2001cited by this paper
• Principles of Multivariate Analysis

  2001cited by this paper
• Quality of Life in the Anxiety Disorders

  2000cited by this paper
• The efficacy of the selective serotonin reuptake inhibitors for social anxiety disorder (social phobia): a meta‐analysis of randomized controlled trials

  2000cited by this paper
• Psychometric properties of the Social Phobia Inventory (SPIN)

  2000influential reference
• An empirical approach to subtype identification in individuals with social phobia

  2000cited by this paper
• Factor structure of social fears: The Liebowitz Social Anxiety Scale.

  1999influential reference
• Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety.

  1998influential reference
• Social phobia subtypes in the National Comorbidity Survey.

  1998cited by this paper
• Factor structure of the Social Interaction Anxiety Scale and the Social Phobia Scale.

  1998influential reference
• A direct-interview family study of generalized social phobia.

  1998cited by this paper
• The Brief Social Phobia Scale: a psychometric evaluation

  1997influential reference
• Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey.

  1996cited by this paper
• Social phobia.

  1995cited by this paper
• The issue of subtypes in the diagnosis of social phobia

  1993cited by this paper
• Phenelzine vs atenolol in social phobia. A placebo-controlled comparison.

  1992cited by this paper
• Principles of multivariate analysis : a user's perspective. oxford

  1988cited by this paper
• Patterns of anxiety: an analysis of social anxieties.

  1957cited by this paper

• A Liebowitz Szociális Szorongás Kérdőív magyar nyelvű validálása, faktorstruktúráinak összehasonlítása és tételeinek modern tesztelméleti elemzése

  2024cites this paper
• Development and initial validation of the Visual Social Anxiety Scale (VSAS): Could a picture be worth a thousand words?

  2022cites this paper
• Anxiety Disorders and OCD in Men

  2021cites this paper
• Therapy of cardioneurosis with modern antidepressants in general medical care network

  2021cites this paper
• Higher- and lower-order personality traits and cluster subtypes in social anxiety disorder

  2020cites this paper
• The psychopharmacology of epilepsy.

  2019cites this paper
• Initial severity and antidepressant efficacy for anxiety disorders, obsessive‐compulsive disorder, and posttraumatic stress disorder: An individual patient data meta‐analysis

  2018cites this paper
• Psychometric properties of the Liebowitz Social Anxiety Scale in a large cross-cultural Spanish and Portuguese speaking sample

  2018cites this paper
• Don't ask, don't tell: a systematic review of the extent to which participant characteristics are reported in social anxiety treatment studies

  2016cites this paper
• The Impact of Social Identities on the Presentation and Treatment of Social Anxiety Disorder

  2016cites this paper
• Accessibility and effectiveness of mental health care for older adults

  2015cites this paper
• Diversity considerations in the assessment and treatment of social anxiety disorder.

  2014cites this paper
• Chapter 22 – Psychopharmacology for Social Anxiety Disorder

  2014cites this paper
• Effectiveness and predictors of outcome in routine out-patient mental health care for older adults

  2014cites this paper
• Post-Marketing Surveillance of Fluvoxamine Maleate Used Long-Term in Patients with Social Anxiety Disorder in Japan

  2014cites this paper
• Evolutionary Perspective on Social Anxiety

  2014cites this paper
• More than a face: a unified theoretical perspective on nonverbal social cue processing in social anxiety

  2013cites this paper
• Open-Label Treatment With Escitalopram in Patients With Social Anxiety Disorder and Fear of Blushing

  2013cites this paper
• 2 Social Anxiety Disorder

  2012cites this paper
• Fear and avoidance of eye contact in social anxiety disorder.

  2011cites this paper
• Neural response to eye contact and paroxetine treatment in generalized social anxiety disorder.

  2011cites this paper
• A comprehensive review of predictive and prognostic composite factors implicated in the heterogeneity of treatment response and outcome across disease areas

  2011cites this paper
• Different Views of Anxiety Disorders

  2011cites this paper
• Treatment Resistant Generalized Anxiety Disorder

  2011cites this paper
• Psychopharmacology for Social Anxiety Disorder

  2010cites this paper
• Subtyping social anxiety disorder in developed and developing countries

  2010cites this paper
• A direct comparison of effect sizes from the clinical global impression‐improvement scale to effect sizes from other rating scales in controlled trials of adult social anxiety disorder

  2009cites this paper
• Influence of escitalopram treatment on 5-HT1A receptor binding in limbic regions in patients with anxiety disorders

  2009cites this paper
• Tratamiento de los trastornos de ansiedad: Diseño y evaluación de una intervención grupal basada en la Inteligencia Emocional

  2009cites this paper
• Ansiedad Social en Estudiantes Universitarios: Prevalencia y Variables Psicosociales Relacionadas

  2008cites this paper
• [Efficacy and tolerability of escitalopram in anxiety disorders: a review].

  2008cites this paper
• Anxiété sociale chez les personnes de très grande taille

  2008cites this paper
• Social Anxiety Disorder

  2008cites this paper
• Escitalopram in the treatment of multisomatoform disorder: a double-blind, placebo-controlled trial

  2008cites this paper
• Practice guideline for the treatment of patients with obsessive-compulsive disorder.

  2007cites this paper
• SSRI effects on pyschomotor performance: assessment of citalopram and escitalopram on normal subjects.

  2007cites this paper
• A 12-month comparison of brief psychodynamic psychotherapy and pharmacotherapy treatment in subjects with generalised anxiety disorders in a community setting

  2007cites this paper
• Examination of the known‐groups validity of the Liebowitz Social Anxiety Scale

  2007cites this paper
• Unmet need for services and interventions among adolescents with mental disorders.

  2007cites this paper
• PRACT ICE GUIDEL INE FOR THE Treatment of Patients With Obsessive-Compulsive Disorder WORK GROUP ON OBSESSIVE-COMPULSIVE DISORDER

  2007cites this paper
• Mise à jour dans le traitement des troubles anxieux

  2007cites this paper
• Social Anxiety Disorder - A Review of Pharmacological Treatments

  2007cites this paper
• Trastorno de ansiedad social

  2006cites this paper
• Escitalopram versus paroxetine for social anxiety disorder: an analysis of efficacy for different symptom dimensions.

  2006cites this paper
• Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

  2006cites this paper
• Social Anxiety Disorder

  2005cites this paper
• Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies.

  2005cites this paper
• Social Anxiety Disorder

  2005cites this paper
• An evaluation of paroxetine in generalised social anxiety disorder

  2005cites this paper
• [Anxiety disorders in women: does gender matter to treatment?].

  2005cites this paper
• Social anxiety disorder

  2003cites this paper